Billie Jean King WTT Charities and Novo Nordisk are offering two scholarships of $5,000 each. Candidates must be between ages 14-21, play tennis competitively, and have diabetes. Deadline for application is May 1, 2006. For more information log on to www.wtt.com/charities.
(PRWEB) January 8, 2006 -- Novo Nordisk, the leading pharmaceutical company in diabetes care, is teaming up with Billie Jean King WTT Charities to present the Novo Nordisk Donnelly Awards. Billie Jean King established the awards in 1998 to encourage diabetic children to lead an active life and compete in tennis. The two awards each provide $5,000 scholarships to young tennis players suffering from diabetes. The award is named after two long-time World Team Tennis executives and tennis champions, Diane Donnelly Stone and Tracy Donnelly Maltby, who are sisters. Stone was an All-American and NCAA doubles champion at Northwestern University, and Maltby earned All-Big Ten honors at the University of Iowa. Both women have had diabetes since childhood.
Two young people, ages 14-21, who have diabetes and play tennis competitively in tournaments or on their school team will receive the $5,000 scholarships. In addition, the recipients will travel to a World Team Tennis match to receive their awards from Billie Jean King. All applications must be received by May 1, 2006, and the winners will be announced by June 15, 2006. For more information and to download an application log on to www.wtt.com and click on BJK/WTT Charities.
Novo Nordisk is a health care company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women.
For further information contact:
Diane Stone
Billie Jean King WTT Charities, Inc
###
|
